Who can I contact to get more information about IVI or to request further details on an IVI project?
For all inquiries, please contact us at info@thevalueinitiative.org and we will connect you with the right team member.
For all inquiries, please contact us at info@thevalueinitiative.org and we will connect you with the right team member.
IVI is actively seeking partnerships with stakeholders across the healthcare industry and we welcome your collaboration. You can get more involved if you: Join IVI. IVI's work is only possible with the support of people and organizations like you. Members of IVI are key partners in advancing the science and practice of value assessment. For more [...]
IVI is a qualified 501(c)(3) tax-exempt organization and donations are tax-deductible to the full extent of the law. IVI's tax ID #83-2257857.
IVI is a membership-funded nonprofit, and IVI's ability to achieve its goal depends on the support of forward-thinking organizations and individuals. By joining IVI, you will connect with a growing collaborative community of researchers, patients, payers, employers, and clinicians committed to modern and flexible value assessment. IVI welcomes both individuals and organizational members, and just [...]
Any individual or organization interested in advancing the science and improving the practice of healthcare value assessment is welcome to become a member of IVI.
Visit our membership page for more information about the options for membership. To become a member or learn more, contact us at info@thevalueinitiative.org.
Healthcare decision makers are increasingly concerned about making choices based on value – but they need reliable information on value to do so. More importantly, they need information that is specific to them and reflects the context of the actual decision. Fields like cost-effectiveness analysis provide a strong foundation, but the reality is that existing [...]
Multiple OSVP-based resources are available: Disease-specific decision models: IVI has released two disease-specific OSVP decision models for simulating outcomes and assessing relative value of treatment sequences in rheumatoid arthritis (IVI-RA) and EGFR+ non-small cell lung cancer (IVI-NSCLC). The models are open-source, and source code and R packages are free to download and customize. Users can also [...]
IVI's OSVP value assessment models have a number of key advantages over these other approaches: Rigorous quantitative analysis: Health benefits, risks and costs are quantified explicitly in OSVP models, making comparison of treatment options more straightforward for decision-makers. Patient-centricity: One of IVI’s primary goals is to improve the ability of value assessment to quantify and incorporate [...]
There are many ways to use IVI's open-source models to compare the value of treatment sequences in specific diseases (currently rheumatoid arthritis and EGFR+ non-small cell lung cancer). These include: Web-based Value Tools: Two apps, designed for different kinds of user, are available for each model: Basic: Streamlined tool designed for a general user and [...]